by CyberKnife Miami | Feb 24, 2021 | Cancer Treatment, Coronavirus Update, COVID19
CDC Reports An Estimated 1 Year Drop in Life Expectancy Due to The COVID Pandemic: This is Why The CyberKnife Center of Miami Never Stopped Treating Patients during the Pandemic, while at the same time taking all necessary safety precautions to protect our cancer...
by CyberKnife Miami | Dec 16, 2020 | COVID19
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that can be completed at home without a prescription. Authorization of the Ellume COVID-19 Home Test is “a major milestone in...
by CyberKnife Miami | May 15, 2020 | Coronavirus Update, COVID19, CyberKnife Center of Miami
How Low-Dose Radiation Could Be The Trick For Treating COVID-19 Using low doses of radiation to treat the deadly inflammation of pneumonia, particularly viral pneumonia like that caused by COVID-19, was used during the first half of the 20th century with good results....
by CyberKnife Miami | May 15, 2020 | Coronavirus Update, COVID19, CyberKnife and Medicare
COVID-19 Concerns Are Interrupting Cancer Treatment – What Can Be Done About It: With the COVID-19 Pandemic making a major impact on the cancer landscape, Dr. Len Lichtenfeld discusses how the coronavirus is impacting the patient’s cancer treatment and...
by CyberKnife Miami | Mar 24, 2020 | COVID19, CyberKnife Center of Miami
A South Florida man on his death bed from the Coronavirus says the drug combination that President Trump talked about saved his life. He was treated at Memorial Regional Hospital in Hollywood, FL on the night he thought would be his last night alive. More than 300...
by CyberKnife Miami | Mar 21, 2020 | Cancer, Cancer Treatment, Coronavirus Update, COVID19, CyberKnife Center of Miami
Cancer Waits For No One – We’re Treating Patients During Coronavirus Pandemic Due to the Coronavirus Pandemic some cancer centers are postponing procedures especially for cancers that are considered slow-growing or early-stage, however our team at...
